Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-02-12 @ 4:18 AM
Study NCT ID:
NCT01962792
Status:
COMPLETED
Last Update Posted:
2021-12-21
First Post:
2013-09-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Organization: